Home›Stock Screener›Wanbury›Quarterly Results

Wanbury Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹20 Cr
QMar 2025
Quarterly Results

In Mar 2025, Wanbury (WANBURY) reported revenue ₹174 Cr and net profit ₹20 Cr — revenue +4.8% YoY. For annual financials, live price and key ratios, visit WANBURY screener.

WANBURY Quarterly Results — Revenue, Profit & EPS Highlights

Wanbury latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. View WANBURY yearly price range for the annual high/low range and current price position.

  • Revenue of ₹174 Cr in Mar 2025 (+6.1% vs Jun 2025, +4.8% vs Mar 2024)
  • Net Profit of ₹20 Cr in Mar 2025 (+42.9% vs Jun 2025, -41.2% vs Mar 2024)
  • EBITDA of ₹32 Cr in Mar 2025 (+28.0% vs Jun 2025)
  • Operating Margin of 17.0% in Mar 2025 (+2.0pp vs Jun 2025)
  • Earnings Per Share of ₹6.18 in Mar 2025 (+50.0% vs Jun 2025)

Wanbury Quarterly Results — Revenue, EBITDA, Net Profit & EPS

WANBURY quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2025 Jun 2025 Sept 2024 Mar 2024 Jun 2024 QoQ YoY
Revenue (₹ Cr) 174 164 163 166 132 6.1% 4.8%
Net Profit (₹ Cr) 20 14 8 34 1 - -
EBITDA (₹ Cr) 32 25 22 45 12 - -
EPS (₹) 6.18 4.12 2.44 10.28 0.32 - -
Operating Margin (%) 17.0% 15.0% 12.0% 13.0% 8.0% - -

WANBURY Share Price Trend — 1-Year Movement Across Quarterly Results

Wanbury 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Analyse WANBURY institutional holdings to track promoter, FII and institutional holdings.

Profitability Ratios

Profit Margin 11.5%
EBITDA Margin 18.4%
Operating Margin 17.0%
ROE (Annual) 135.6%

Balance Sheet Highlights

Total Assets ₹414 Cr
Total Equity ₹59 Cr
Current Assets ₹193 Cr
Current Liabilities ₹180 Cr

Cash Flow Analysis

Operating Cash Flow ₹26 Cr
Investing Cash Flow ₹-51 Cr
Financing Cash Flow ₹26 Cr
Net Cash Flow ₹1 Cr

Current Market Data

Current Price ₹222.75
Exchange NSE
Last Updated Sep 18, 2026

Revenue Trend (₹ Cr)

Mar 2024 166
Sept 2024 163
Jun 2025 164
Mar 2025 174

Net Profit Trend (₹ Cr)

Mar 2024 34
Sept 2024 8
Jun 2025 14
Mar 2025 20

Operating Margin Trend (%)

Mar 2024 13.0%
Sept 2024 12.0%
Jun 2025 15.0%
Mar 2025 17.0%

WANBURY vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Wanbury latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹441,477.63 Cr 1837.3 15,018 2,710 -5.6% - 18.0% 162.6
Divis Laboratories
Mar 2026 		₹247,469.81 Cr 9375.0 2,986 751 -5.0% - 25.2% 331.2
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4840.0 4,111 364 +27.7% +42.2% 8.9% 420.5
Zydus Life Science
Mar 2026 		₹112,607.65 Cr 1160.0 7,569 1,341 -4.3% - 17.7% 91.7
Cipla
Mar 2026 		₹109,705.39 Cr 1394.5 6,612 543 -9.3% - 8.2% 203.0
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores